AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
NEWS
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Pfizer and BioNTech Report Strong Immune Response from LP.8.1...
Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...